Task: Answer the multiple-choice question.
Question: Which drug exhibits a -11.654% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: C/C(=N\NC(=O)c1ccc2nc[nH]c2c1)c1ccc([N+](=O)[O-])cc1
b: COc1ccc(OC)c(CCNC(=O)c2sc3nc4n(c(=O)c3c2C)CCC4)c1
c: CC(=O)c1cc(-c2ccccc2)n(CCC(=O)NC2CCCCCC2)c1C
d: Cc1c(OCc2ccccc2)c(=O)ccn1Cc1ccc(Cl)cc1
e: CC(=O)c1[nH]c(C)c(C(=O)N2CCCC(Nc3cccc(F)c3)C2)c1C
Answer: c. CC(=O)c1cc(-c2ccccc2)n(CCC(=O)NC2CCCCCC2)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)c1cc(-c2ccccc2)n(CCC(=O)NC2CCCCCC2)c1C
CC(=O)c1cc(-c2ccccc2)n(CCC(=O)NC2CCCCCC2)c1C
3-(3-acetyl-2-methyl-5-phenylpyrrol-1-yl)-N-cycloheptylpropanamide